Quantitative and qualitative characterization of Two PD-L1 clones: SP263 and E1L3N

被引：0
|
作者：
Jacquelyn Smith
Mark D. Robida
Krista Acosta
Bharathi Vennapusa
Amita Mistry
Greg Martin
Alton Yates
H. James Hnatyszyn
机构：
[1] Ventana Medical Systems Inc.,Companion Diagnostics Pharma Services, Assay Development
[2] Roche Tissue Diagnostics,Companion Diagnostics Pharma Services, Pathology Office
[3] Ventana Medical Systems Inc.,Companion Diagnostics, Project Management Office
[4] Roche Tissue Diagnostics,Companion Diagnostics, Pharma Services, Clinical Services Management
[5] Ventana Medical Systems Inc.,Companion Diagnostics Pharma Services, CDx CAP/CLIA Lab Operations
[6] Roche Tissue Diagnostics,undefined
[7] Ventana Medical Systems Inc.,undefined
[8] Roche Tissue Diagnostics,undefined
[9] Ventana Medical Systems Inc.,undefined
[10] Roche Tissue Diagnostics,undefined
来源：
Diagnostic Pathology | / 11卷
关键词：
PD-L1; IHC; NSCLC; SP263; E1L3N;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Comparison of PD-L1 Assays in Non-small Cell Lung Cancer: 22C3 pharmDx and SP263
    Fujimoto, Daichi
    Yamashita, Daisuke
    Fukuoka, Junya
    Kitamura, Yuka
    Hosoya, Kazutaka
    Kawachi, Hayato
    Sato, Yuki
    Nagata, Kazuma
    Nakagawa, Atsushi
    Tachikawa, Ryo
    Date, Naoki
    Sakanoue, Ichiro
    Hamakawa, Hiroshi
    Takahashi, Yutaka
    Tomii, Keisuke
    ANTICANCER RESEARCH, 2018, 38 (12) : 6891 - 6895
  • [42] PD-L1 expression with QR1 and E1L3N antibodies according to histological ovarian cancer subtype: A series of 232 cases
    Eymerit-Morin, Caroline
    Ilenko, Anna
    Gaillard, Thomas
    Varinot, Justine
    Comperat, Eva
    Bendifallah, Sofiane
    Darai, Emile
    EUROPEAN JOURNAL OF HISTOCHEMISTRY, 2021, 65 (01):
  • [43] PD-L1 immunohistochemical expression in bladder urothelial cancer with SP263, SP142 and 22C3 antibodies: A comparative study
    Paliogiannis, Panagiotis
    Lobrano, Renato
    Bella, Michele Angelo
    Fara, Antonella
    Uras, Maria Gabriela
    Pinna, Maria Antonia
    Tedde, Alessandro
    Madonia, Massimo
    Zinellu, Angelo
    Cossu, Antonio
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2024, 69
  • [44] Inter-rater reliability of programmed death ligand 1 ( PD-L1) scoring using the VENTANA PD-L1 (SP263) assay in non-small cell lung cancer (NSCLC)
    Williams, G. H.
    Nicholson, A. G.
    Snead, D. R. J.
    Thunnissen, E.
    Lantuejoul, S.
    Cane, P.
    Kerr, K. M.
    Loddo, M.
    Scott, M.
    Scorer, P. W.
    Barker, C.
    ANNALS OF ONCOLOGY, 2018, 29
  • [45] Interobserver Reliability of Programmed Cell Death Ligand-1 Scoring Using the VENTANA PD-L1 (SP263) Assay in NSCLC
    Williams, Gareth H.
    Nicholson, Andrew G.
    Snead, David R. J.
    Thunnissen, Erik
    Lantuejoul, Sylvie
    Cane, Paul
    Kerr, Keith M.
    Loddo, Marco
    Scott, Marietta L. J.
    Scorer, Paul W.
    Barker, Craig
    JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (04) : 550 - 555
  • [46] Validation of E1L3N antibody for PD-L1 detection and prediction of pembrolizumab response in non-small-cell lung cancer
    Lianxi Song
    Liang Zeng
    Huan Yan
    Qinqin Xu
    Qing Xia
    Jian Lei
    Xiaoyan Chen
    Xiaoping Hu
    Zhan Wang
    Hong Liu
    Nong Yang
    Yongchang Zhang
    Communications Medicine, 2
  • [47] Investigation of PD-L1 expression and tislelizumab efficacy in gastroesophageal adenocarcinoma using a novel tumor and immune cell score with VENTANA PD-L1 (SP263) assay and Combined Positive Score (CPS)
    Chao, Y.
    Yang, S.
    Zhang, Y.
    Shen, Z.
    Wu, X.
    Wang, J.
    Quiroz, M.
    Nielsen, A.
    Liu, C.
    Desai, J.
    ANNALS OF ONCOLOGY, 2020, 31 : S300 - S300
  • [48] CT-guided transthoracic needle biopsy for evaluation of PD-L1 expression: Comparison of 22C3 and SP263 assays
    Beck, Kyongmin S.
    Kim, Seung Joon
    Kang, Jin Hyoung
    Han, Dae Hee
    Jung, Jung Im
    Lee, Kyo Young
    THORACIC CANCER, 2019, 10 (07) : 1612 - 1618
  • [49] CT-Guided Transthoracic Needle Biopsy for Evaluation of PD-L1 Expression: Comparison of 22C3 and SP263 Assays
    Beck, K.
    Lee, K. Y.
    Hong, S. J.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S399 - S400
  • [50] Clinical significance of ≥ 50% PD-L1 expression with the SP263 monoclonal antibody in non-small cell lung cancer patients
    Li, Wenbin
    Song, Peng
    Guo, Lei
    Liu, Xiuyun
    Guo, Changyuan
    Ying, Jianming
    Gao, Shugeng
    THORACIC CANCER, 2019, 10 (02) : 175 - 182
12345